PE20060723A1 - Derivados de morfina como agentes analgesicos - Google Patents

Derivados de morfina como agentes analgesicos

Info

Publication number
PE20060723A1
PE20060723A1 PE2005001291A PE2005001291A PE20060723A1 PE 20060723 A1 PE20060723 A1 PE 20060723A1 PE 2005001291 A PE2005001291 A PE 2005001291A PE 2005001291 A PE2005001291 A PE 2005001291A PE 20060723 A1 PE20060723 A1 PE 20060723A1
Authority
PE
Peru
Prior art keywords
alcoxy
morphinan
ona
cyclopropylmethyl
dihydroxy
Prior art date
Application number
PE2005001291A
Other languages
English (en)
Spanish (es)
Inventor
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PE20060723A1 publication Critical patent/PE20060723A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2005001291A 2004-11-04 2005-11-03 Derivados de morfina como agentes analgesicos PE20060723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04

Publications (1)

Publication Number Publication Date
PE20060723A1 true PE20060723A1 (es) 2006-08-29

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001291A PE20060723A1 (es) 2004-11-04 2005-11-03 Derivados de morfina como agentes analgesicos

Country Status (12)

Country Link
US (1) US8470845B2 (enExample)
EP (1) EP1820505A4 (enExample)
JP (1) JP4706636B2 (enExample)
KR (1) KR101285645B1 (enExample)
CN (1) CN101090722B (enExample)
AR (1) AR053098A1 (enExample)
CA (1) CA2586181C (enExample)
MX (1) MX2007005336A (enExample)
NO (1) NO20072832L (enExample)
PE (1) PE20060723A1 (enExample)
TW (1) TW200621785A (enExample)
WO (1) WO2006049248A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101356176B (zh) 2005-11-09 2011-12-21 东丽株式会社 功能性肠病的治疗或预防药
CA2634055C (en) 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
ES2648037T3 (es) * 2007-05-21 2017-12-28 Toray Industries, Inc. Preparación oral que comprende un ácido orgánico específico y método para mejorar la propiedad de disolución y la estabilidad química de la preparación oral
KR101510799B1 (ko) * 2007-05-21 2015-04-10 도레이 카부시키가이샤 의약 정제의 제조법
JP5564943B2 (ja) * 2007-05-21 2014-08-06 東レ株式会社 結晶性微粉化粒子
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
PT3761982T (pt) 2018-03-08 2024-12-30 Univ Kansas Utilização da nalfurafina no tratamento de doenças desmielinizantes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (enExample) * 1964-02-03 1966-10-31
US3318884A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6-demethoxythebaine and 6-amino-6-demethoxyoripavine derivatives
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
CA2105072C (en) * 1992-01-23 1998-07-28 Hiroshi Nagase Morphinan derivative and its pharmaceutical applications
AU686203B2 (en) 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
JP3348230B2 (ja) * 1995-03-03 2002-11-20 アルゴス ファーマシューティカル コーポレーション 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用
CN1374963A (zh) * 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
DE60109960T2 (de) 2000-10-31 2006-02-16 Rensselaer Polytechnic Institute 8-substituierte 2,6-methano-3-benzazocine und 3-substituierte morphinane als opioidrezeptorbindende agenzien
CA2501389C (en) 2002-10-09 2013-01-08 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
ATE414516T1 (de) 2004-03-30 2008-12-15 Toray Industries Morphinanderivate als mittel gegen juckreiz

Also Published As

Publication number Publication date
CA2586181A1 (en) 2006-05-11
CN101090722B (zh) 2011-12-21
TWI356826B (enExample) 2012-01-21
TW200621785A (en) 2006-07-01
EP1820505A4 (en) 2010-01-20
US8470845B2 (en) 2013-06-25
NO20072832L (no) 2007-08-01
MX2007005336A (es) 2007-06-25
CA2586181C (en) 2012-11-27
AR053098A1 (es) 2007-04-25
WO2006049248A1 (ja) 2006-05-11
US20070299100A1 (en) 2007-12-27
KR20070085436A (ko) 2007-08-27
CN101090722A (zh) 2007-12-19
JP4706636B2 (ja) 2011-06-22
KR101285645B1 (ko) 2013-07-12
HK1115808A1 (en) 2008-12-12
JPWO2006049248A1 (ja) 2008-08-07
EP1820505A1 (en) 2007-08-22

Similar Documents

Publication Publication Date Title
PE20110568A1 (es) Agentes terapeuticos 414
PE20120355A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20011119A1 (es) Composiciones farmaceuticas de agonista/antagonista de estrogenos para el tratamiento de afecciones que responden a un aumento de testosterona
SE0200979D0 (sv) New compounds
PE20010925A1 (es) Compuestos inhibidores del neuropeptido y utiles para el tratamiento de la disfuncion sexual femenina
PE20071061A1 (es) Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf)
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20020573A1 (es) Derivados glucopiranosiloxibencilbenceno, composiciones farmaceuticas que los comprenden e intermedios de los mismos
ECSP088863A (es) Compuestos que son agonistas de receptores muscarínicos y que pueden ser eficaces en el tratamiento del dolor, la enfermedad de alzheimer y/o la esquizofrenia
PE20110222A1 (es) Inhibidores de dipeptidilpeptidasa iv
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
PE20141681A1 (es) Inhibidores de btk
PE20070018A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
PE20060723A1 (es) Derivados de morfina como agentes analgesicos
PE20030497A1 (es) Combinaciones de un inhibidor de pde 5 y otros agentes activos
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
PE20060186A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion asi como su uso como medicamento
PE20081596A1 (es) Derivados fluorinados de deferiprona
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
AR059501A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
PE20050732A1 (es) Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
PE20100052A1 (es) Derivados de 3-oxoisoindolin-1-carboxamida como inhibidores de los canales de sodio
RU2008129723A (ru) Ингибиторы ccr9 активности

Legal Events

Date Code Title Description
FC Refusal